The prognostic value of tumor microenvironment in endometrioid type endometrial cancer: Effect of CD44 on oncologic outcome
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.16071 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Zehra Ozturk Basarir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Ankara City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Hyaluronan Receptors, Tumor Microenvironment, Carcinoma, Endometrioid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Objectives
The study aimed to evaluate the expression of CD44, CD47, interleukin‐1 (IL‐1), and tumor necrosis factor alpha (TNF‐α) in immunohistochemically stained (IHS) samples from endometrioid endometrial cancer (EEC) and to examine their correlation with clinicopathologic parameters.
Methods
IHS was used to assess CD44, CD47, IL‐1, and TNF‐α expression in 53 EEC samples. Immunostaining was scored as negative (−), slightly positive (+), moderately positive (++), or strongly/diffuse positive (+++). The prognostic value of these markers was analyzed in relation to clinicopathologic features, including survival.
Results
In endometrial cancer tissues, positivity rates were CD44 (81%), CD47 (81%), TNF‐α (40.5%), and IL‐1 (42.9%). Strong and diffuse CD44 staining was associated with improved survival and linked to endocervical invasion and stage. Patients with slightly positive CD47 had significantly higher rates of pelvic and para‐aortic lymph node metastases. Strong TNF‐α staining correlated with grade 3 EEC, while slightly positive IL‐1 staining was associated with increased endocervical invasion. No significant correlation was found between CD47, IL‐1, and TNF‐α expression and survival.
Conclusion
CD44 and CD47 were positive in most EEC specimens. CD44 expression was the only marker significantly correlated with overall survival and recurrence. TNF‐α showed a positive correlation with high‐grade tumors, and IL‐1 staining was inversely associated with endocervical invasion. These findings suggest that CD44 is a prognostic marker for survival, while TNF‐α and IL‐1 may have indirect prognostic roles in EEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Ankara City Hospital, Ankara, Turkey.
- Department of Pathology, Ankara Research and Training Hospital, Ankara, Turkey.
- Department of Anesthesiology, Ankara Research and Training Hospital, Ankara, Turkey.
- Department of Obstetrics and Gynecology, Ankara Research and Training Hospital, Ankara, Turkey.
ORCID-Profile: Zehra Ozturk Basarir, Muzaffer Caydere, Sefika Karabulut, Mustafa Sirri Kotanoglu, Tufan Arslanca, Yeşim Özkaya Uçar, Yusuf Üstün
Zitieren
APA
Basarir, Z. O., Caydere, M., Karabulut, S., Kotanoglu, M. S., Arslanca, T., Uçar, Y. Ö., & Üstün, Y. (2025). The prognostic value of tumor microenvironment in endometrioid type endometrial cancer: Effect of CD44 on oncologic outcome. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.16071
Vancouver
Basarir ZO, Caydere M, Karabulut S, Kotanoglu MS, Arslanca T, Uçar YÖ, et al. The prognostic value of tumor microenvironment in endometrioid type endometrial cancer: Effect of CD44 on oncologic outcome. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.16071
BibTeX
@article{Basarir2025,
author = {Basarir, Zehra Ozturk and Caydere, Muzaffer and Karabulut, Sefika and Kotanoglu, Mustafa Sirri and Arslanca, Tufan and Uçar, Yeşim Özkaya and Üstün, Yusuf},
title = {The prognostic value of tumor microenvironment in endometrioid type endometrial cancer: Effect of CD44 on oncologic outcome},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.16071}
}
EUVIMED